Dr PBN Prasad To Hold Charge As DCGI On Temporary Basis

New Delhi  (ANI): Dr PBN Prasad will hold the charge of the post of Drugs Controller General of India from February 16 to 28 this year or until further orders, an official notice said on Wednesday.

According to the official notice issued by Dr Kiran Kumar Karlapu, Deputy Secretary to the Government of India, “It has been decided with the approval of the Competent Authority, that Dr PBN Prasad, JDC(I) shall hold the charge of the post of Drug Controller of (India) under FR 49(v)wef 16.02.2023 till 28.02.2023 (date of his superannuation) or until further orders, whichever is earlier.”

Recently, UPSC recommended the name of Dr Rajeev Singh Raghuvanshi as the new Drugs Controller General of India (DCGI).

The Union Public Service Commission (UPSC) conducted interviews for the appointment of the DCGI last week. The top contenders were Dr VG Somani, Dr Rajeev Singh Raghuvanshi and Dr Jai Prakash. According to the sources soon final name will be announced.

Earlier in November last year, Dr V G Somani’s term as Drugs controller general of India (DCGI) was extended for three months that came into effect from November 16 last year. This was done the second time, however, earlier he got an extension in the month of August 22.

Dr Kiran Kumar Karlapu, Deputy Secretary, Department of Health and Family Welfare issued the circular regarding the extension of DCGI for a further period of three months.

Dr V G Somani was appointed as Drugs Controller General of India in the month of August 2019, DCGI heads the Central Drugs Standard Control Organisation (CDSCO) which is responsible for ensuring quality drug supply across the country. It also has the authority to give approval to new drugs and regulate clinical trials. (ANI)

  • Related Posts

    • Pharma
    • July 12, 2024
    • 14 views
    14 Barred Patanjali Products Sold Across Counter At Dedicated Stores

    Delhi/lucknow/patna/ Dehradun: On Tuesday morning, the Supreme Court of India directed Patanjali Ayurved to provide proof that it has ceased the sale and advertisements of 14 products banned by the Uttarakhand…

    • Pharma
    • July 12, 2024
    • 39 views
    Mumbai: FDA Conducts Raids At Three Different Locations In Vasai, Seized Ayurvedic Drugs Worth Rs 1.41 Crore

    Vasai: Food and Drug Administration (FDA) Maharashtra conducted raids at three different locations at Vasai on Thursday and found that a Pharma Products Pvt Limited company was manufacturing drugs without obtaining…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    14 Barred Patanjali Products Sold Across Counter At Dedicated Stores

    14 Barred Patanjali Products Sold Across Counter At Dedicated Stores

    Mumbai: FDA Conducts Raids At Three Different Locations In Vasai, Seized Ayurvedic Drugs Worth Rs 1.41 Crore

    Mumbai: FDA Conducts Raids At Three Different Locations In Vasai, Seized Ayurvedic Drugs Worth Rs 1.41 Crore

    Telangana DCA Raids 2 Places, Seizes Illegally Stocked And Overpriced Medicines

    Telangana DCA Raids 2 Places, Seizes Illegally Stocked And Overpriced Medicines

    PGI Developed ABC Device To Compete With Ventilator

    PGI Developed ABC Device To Compete With Ventilator

    Bharat Biotech Readying ForTuberculosis, Cholera Vaccines

    Bharat Biotech Readying ForTuberculosis, Cholera Vaccines

    Delhi HC Bans Zydus’ Biosimilar Sigrima In A Landmark Injunction Order

    Delhi HC Bans Zydus’ Biosimilar Sigrima In A Landmark Injunction Order